Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.917
-0.113 (-11.01%)
At close: Nov 21, 2024, 4:00 PM
0.962
+0.046 (5.00%)
After-hours: Nov 21, 2024, 4:04 PM EST
Lyell Immunopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -203.99 | -234.63 | -183.12 | -250.22 | -204.47 | -129.38 |
| Depreciation & Amortization | 19.66 | 20.25 | 18.02 | 13.62 | 4.29 | 1.26 |
| Loss (Gain) From Sale of Assets | 0.85 | 1.51 | 0.1 | 1.21 | -4.88 | - |
| Loss (Gain) From Sale of Investments | -2.15 | 3.33 | 1.15 | 38.35 | 0.54 | -1.52 |
| Stock-Based Compensation | 33.52 | 47.08 | 81.92 | 62.2 | 33.26 | 15.73 |
| Other Operating Activities | -2.26 | -4.65 | -5.62 | 4.57 | 10.72 | 42.57 |
| Change in Accounts Payable | -0.77 | 1.46 | 0.67 | 0.09 | -0.28 | 1.71 |
| Change in Unearned Revenue | - | - | -84.65 | -10.51 | -7.76 | 102.92 |
| Change in Other Net Operating Assets | -0.66 | 1.96 | 1.97 | 14.43 | 7.7 | 6.18 |
| Operating Cash Flow | -155.79 | -163.69 | -169.56 | -126.25 | -160.87 | 39.47 |
| Capital Expenditures | -0.45 | -2.69 | -24.28 | -65.5 | -51.48 | -16.05 |
| Investment in Securities | -31.33 | 186.73 | 12.74 | -56.07 | -222.04 | -406.39 |
| Investing Cash Flow | -31.77 | 184.05 | -11.54 | -121.57 | -273.52 | -422.43 |
| Issuance of Common Stock | 1.85 | 2.2 | 11.1 | 401.24 | 0.37 | - |
| Repurchase of Common Stock | -0.2 | -0.46 | -0.46 | - | -11.81 | -0.19 |
| Financing Cash Flow | 1.65 | 1.74 | 10.64 | 401.24 | 476.79 | 351.16 |
| Net Cash Flow | -185.91 | 22.1 | -170.46 | 153.42 | 42.4 | -31.8 |
| Free Cash Flow | -156.23 | -166.38 | -193.83 | -191.75 | -212.36 | 23.43 |
| Free Cash Flow Margin | -247987.30% | -127984.62% | -228.89% | -1800.50% | -2737.94% | 3565.75% |
| Free Cash Flow Per Share | -0.61 | -0.66 | -0.78 | -1.41 | -16.02 | 4.32 |
| Levered Free Cash Flow | -83.12 | -90.36 | -53.9 | -129.82 | -128 | - |
| Unlevered Free Cash Flow | -83.12 | -90.36 | -53.9 | -129.82 | -128 | - |
| Change in Net Working Capital | 0.7 | 1.57 | 12.73 | 6.66 | -23.25 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.